Physician profile
Daniel Wise
NPI 1780625319
$24,205.30
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $4,925 · 2023: $23.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17,759.75 | 2019 | |
| Esperion Therapeutics, INC. | $4,924.99 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.28 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $209.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $162.62 | 2019 | |
| Novo Nordisk INC | $129.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $127.63 | 2019 | |
| Boston Scientific Corporation | $101.97 | 2019 | |
| Sanofi-Aventis U.S. LLC | $88.64 | 2019 | |
| Amarin Pharma, INC. | $71.54 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $57.46 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $42.78 | 2019 | |
| Lilly USA, LLC | $42.26 | 2019 | |
| Edwards Lifesciences Corporation | $41.88 | 2019 | |
| Abbvie INC. | $38.72 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $35.63 | 2019 | |
| Merck Sharp & Dohme LLC | $29.10 | 2019 | |
| W. L. Gore & Associates, INC. | $23.38 | 2023 | Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Pfizer INC. | $21.60 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $17.09 | 2019 | |
| Gilead Sciences, INC. | $16.89 | 2019 | |
| Eisai INC. | $14.74 | 2019 | |
| Amneal Pharmaceuticals LLC | $13.70 | 2019 | |
| Vivus LLC | $13.22 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.